Knight Therapeutics Receives Approval For Tavalisse in Brazil-May 2024-www.financetom.com

World

Knight Therapeutics Receives Approval For Tavalisse in Brazil

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Knight Therapeutics Receives Approval For Tavalisse in Brazil

May 8, 2026 5:22 AM

07:48 AM EDT, 05/08/2026 (MT Newswires) -- Knight Therapeutics ( KHTRF ) has received regulatory approval from the Brazil health authorities for Tavalisse (fostamatinib disodium hexahydrate), the company said on Friday.

Tavalisse is prescribed for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Tavalisse is expected to launch in Brazil in the second half of this year.

Knight Therapeutic shares closed up $0.84, to $8.35 on Thursday on the Toronto Stock Exchange.

Previous page： Traders Eye Fed Rate Decision as US Equity Futures Inch Higher Pre-Bell Next page： Wall St set for higher open as markets gear up for Fed decision

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Traders Eye Fed Rate Decision as US Equity Futures Inch Higher Pre-Bell

Dec 18, 2024

09:09 AM EST, 12/18/2024 (MT Newswires) -- US equity futures posted narrow gains before Wednesday's opening bell as traders looked ahead to the Federal Reserve's interest rate decision. Dow Jones Industrial Average futures gained 0.4%, S&P 500 futures increased 0.2% and Nasdaq futures were up 0.1%. Oil prices were higher, with front-month global benchmark North Sea Brent crude up 0.7%...

Wall St set for higher open as markets gear up for Fed decision

Dec 18, 2024

(Reuters) -Wall Street's main indexes were poised for a higher open on Wednesday, as investors were optimistic about the Federal Reserve's final rate decision of the year and awaited signals on whether policymakers will take a more cautious stance in 2025. The Fed is widely expected to reduce interest rates by 25 basis points at its meeting. The announcement is...

Brazilian assets struggle to contain selloff in febrile markets

Dec 18, 2024

LONDON, Dec 18 (Reuters) - Brazil's real struggled to claw back some of its hefty losses on Wednesday and the cost of insuring exposure to its debt lingered near a 14-month high with markets febrile as Latin America's largest economy faces a deepening financial crisis. Brazilian assets from stocks to bonds and its currency have found themselves in the crosshairs...

CANADA STOCKS-Toronto shares slip ahead of Fed decision

Dec 18, 2024

Dec 18 (Reuters) - Canada's main stock index edged lower on Wednesday, led by gold miners and material stocks, ahead of the U.S. Federal Reserve's monetary policy decision. At 9:32 a.m. ET, the Toronto Stock Exchange's S&P/TSX composite index was down 0.2% at 25,085.42 points. ...